A patient with stable angina, poorly controlled diabetes, and hyperlipidemia presents with ST-segment depression on an ECG and elevated LDL cholesterol levels. Which intervention should the nurse prioritize to address the most immediate risk factor for cardiac events in this patient?

B) Recommend the initiation of a beta-blocker to reduce myocardial oxygen demand

A) Increase the dose of atorvastatin to better control LDL levels

B) Recommend the initiation of a beta-blocker to reduce myocardial oxygen demand

C) Educate the patient on dietary changes to improve overall cardiac health

D) Review and adjust the patient's metformin dosage to improve glycemic control

A patient with stable angina and poorly controlled diabetes and hyperlipidemia is currently taking amlodipine, metformin, atorvastatin, and aspirin. Based on their recent diagnostic results, which additional intervention should the nurse prioritize in the care plan to reduce the risk of future cardiac events?

B) Recommend intensive lifestyle modifications, including dietary changes and a structured exercise program.

A) Increase the dose of amlodipine to improve blood pressure control.

B) Recommend intensive lifestyle modifications, including dietary changes and a structured exercise program.

C) Suggest adding a beta-blocker to decrease myocardial oxygen demand.

D) Advocate for an increase in metformin dosage to better manage blood glucose levels.

A patient with a history of angina and diabetes has recently started on a beta-blocker and a GLP-1 receptor agonist. They report increased fatigue and dizziness upon standing, with a blood pressure of 96/58 mmHg and heart rate of 58 bpm. Considering the current symptoms and medication regimen, what is the nurse's priority intervention?

C) Discuss with the healthcare provider the need to adjust the beta-blocker dosage.

A) Advise the patient to increase fluid intake to manage dizziness.

B) Educate the patient on the importance of rising slowly to prevent orthostatic hypotension.

C) Discuss with the healthcare provider the need to adjust the beta-blocker dosage.

D) Encourage the patient to increase physical activity to improve cardiovascular health.

A patient with a history of angina and type 2 diabetes has been started on a beta-blocker and a GLP-1 receptor agonist. During a follow-up visit, the patient reports increased fatigue and dizziness, especially when standing. Vital signs show a blood pressure of 96/58 mmHg and a heart rate of 58 bpm. Which of the following is the most appropriate nursing intervention?

D) Instruct the patient to change positions slowly to prevent dizziness from orthostatic hypotension.

A) Advise the patient to increase fluid intake to manage hypotension.

B) Educate the patient on the signs of hypoglycemia related to GLP-1 receptor agonist use.

C) Recommend the patient to take the beta-blocker at night to reduce daytime fatigue.

D) Instruct the patient to change positions slowly to prevent dizziness from orthostatic hypotension.

A patient with a history of hypertension and type 2 diabetes mellitus has recently experienced an adjustment in beta-blocker dosage and initiated dietary interventions. He now reports episodes of mild shortness of breath and palpitations during exertion. An ECG shows occasional premature ventricular contractions (PVCs), and lab results indicate a slightly elevated potassium level. Based on this information, which nursing intervention is the most appropriate to address the patient's current symptoms?

B) Educate the patient on avoiding high-potassium foods in his diet.

A) Increase the patient's fluid intake to help reduce potassium levels.

B) Educate the patient on avoiding high-potassium foods in his diet.

C) Recommend the patient to skip doses of the beta-blocker when experiencing palpitations.

D) Encourage the patient to rest and avoid physical exertion until symptoms resolve.

A patient with a history of hypertension and diabetes is experiencing mild shortness of breath and palpitations during exertion. An ECG reveals occasional premature ventricular contractions (PVCs), and lab results indicate a slightly elevated potassium level of 5.3 mmol/L. Which nursing intervention is most appropriate to address the patient's symptoms and lab findings?

C) Instruct the patient to adhere to a low-potassium diet and review their current medication list with the healthcare provider.

A) Encourage the patient to increase intake of potassium-rich foods to stabilize cardiac function.

B) Advise the patient to avoid sudden position changes to prevent dizziness and potential falls.

C) Instruct the patient to adhere to a low-potassium diet and review their current medication list with the healthcare provider.

D) Recommend increasing fluid intake to help dilute elevated potassium levels and reduce cardiac irritability.

A patient with frequent premature ventricular contractions (PVCs) and occasional runs of ventricular tachycardia is experiencing increased shortness of breath and palpitations. The patient's potassium level is elevated at 5.4 mmol/L. Which nursing intervention is most appropriate to address the patient's risk for further cardiac arrhythmias?

A) Educate the patient on reducing dietary potassium intake.

B) Encourage increased physical activity to improve cardiovascular fitness.

C) Suggest the patient avoids all beta-blocker medications.

D) Instruct the patient to consume more fluids to dilute potassium levels.

A patient with frequent PVCs and an elevated potassium level is being monitored for potential cardiac complications. Which nursing intervention is most appropriate to prevent further arrhythmias in this patient?

B) Monitor the patient's cardiac rhythm closely and report any runs of ventricular tachycardia immediately.

A) Encourage the patient to consume foods high in potassium to balance the medication side effects.

B) Monitor the patient's cardiac rhythm closely and report any runs of ventricular tachycardia immediately.

C) Advise the patient to increase fluid intake to dilute potassium levels in the bloodstream.

D) Recommend increasing the dosage of the patient's beta-blocker to suppress arrhythmias.

A patient with a history of stable angina and arrhythmias reports mild dizziness when standing up quickly. His blood pressure is 92/58 mmHg, and he is on a beta-blocker. What is the most appropriate nursing intervention to address the patient's orthostatic symptoms?

C) Instruct the patient to change positions slowly from lying to standing.

A) Advise the patient to increase fluid and salt intake.

B) Recommend the patient sit down immediately when feeling dizzy.

C) Instruct the patient to change positions slowly from lying to standing.

D) Suggest stopping the beta-blocker immediately to raise blood pressure.

A patient with stable angina and a recent medication adjustment returns with symptoms of mild dizziness upon standing and a blood pressure of 92/58 mmHg. Which nursing intervention is most appropriate at this time to address the patient's current symptoms?

A) Encourage the patient to increase fluid intake to manage low blood pressure.

B) Instruct the patient to avoid all physical activity until symptoms resolve.

C) Advise the patient to consume a high-potassium diet to correct electrolyte imbalances.

D) Recommend elevating the head of the bed to reduce orthostatic hypotension.

stable angina - Nursing Case Study

Pathophysiology

• Primary mechanism: Stable angina is primarily caused by atherosclerosis, where plaque buildup in coronary arteries narrows them, reducing blood flow and oxygen supply to the heart muscle during increased demand, such as physical exertion.

• Secondary mechanism: Endothelial dysfunction further contributes by impairing the vessels' ability to dilate, limiting compensatory blood flow increase during exertion, exacerbating ischemic conditions.

• Key complication: If not managed, stable angina can progress to unstable angina or myocardial infarction due to further plaque growth or rupture, leading to acute coronary syndromes.

Patient Profile

Demographics:

58-year-old male, accountant

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Amlodipine, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain during physical activity

• Key symptoms: Chest discomfort radiating to the left arm, shortness of breath, fatigue

• Vital signs: Blood pressure 145/90 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decides to conduct a series of diagnostic tests to further evaluate the extent of the patient's condition. An electrocardiogram (ECG) is performed immediately, revealing ST-segment depression, which is indicative of subendocardial ischemia commonly associated with stable angina. To gain more insight, a stress test is scheduled, which further shows significant ST-segment changes and reproduces the patient's chest pain symptoms when his heart rate reaches 130 bpm. This suggests that the coronary blood flow is insufficient during increased physical exertion.

Additionally, laboratory tests are conducted to assess cardiac risk factors and overall health status. The results reveal elevated LDL cholesterol at 160 mg/dL and HbA1c at 8.2%, indicating poorly controlled hyperlipidemia and diabetes, respectively. Troponin levels remain within normal limits, ruling out an acute myocardial infarction at this stage. However, the elevated cholesterol levels and suboptimal diabetes control highlight the need for intensified management to prevent further complications such as unstable angina or myocardial infarction.

Given these findings, the healthcare team discusses the need for optimizing the patient's treatment regimen. While the current use of amlodipine, metformin, atorvastatin, and aspirin provides a foundational approach, it's evident that adjustments are necessary to better control the patient's risk factors. Potential changes might include intensifying statin therapy, introducing a beta-blocker to further reduce myocardial oxygen demand, or optimizing glycemic control with additional or alternative antidiabetic agents. The patient is also counseled on lifestyle modifications, such as dietary changes and a tailored exercise program, to complement pharmacological interventions and reduce the risk of future cardiac events.

Section 2

Change in Patient Status

Following the initiation of intensified therapeutic measures, including the addition of a beta-blocker to the patient's regimen and adjustments in his diabetes management with the introduction of a GLP-1 receptor agonist, the patient initially reports a slight improvement in his angina symptoms. However, during a routine follow-up appointment two weeks later, the patient mentions experiencing increased fatigue and occasional dizziness, particularly upon standing. Vital signs reveal a blood pressure of 96/58 mmHg and a heart rate of 58 bpm, suggesting a potential side effect of the new beta-blocker therapy. The healthcare team acknowledges the need to reassess the medication dosage to avoid hypotension and bradycardia that could impair perfusion and exacerbate the patient's cardiovascular risk.

In addition to these symptoms, the patient expresses difficulty adhering to the recommended lifestyle modifications due to ongoing issues with dietary compliance and lack of motivation for physical activity. Despite the initial dietary counseling, the patient reports challenges in reducing saturated fat intake and increasing consumption of heart-healthy foods. Furthermore, his HbA1c remains elevated at 8.0%, indicating the need for further engagement in diabetes self-management education and support.

The healthcare team decides to adjust the beta-blocker dosage while intensifying educational efforts to empower the patient in making sustainable lifestyle changes. A referral to a dietitian for personalized nutritional guidance and participation in a cardiac rehabilitation program is recommended to enhance adherence and improve overall cardiovascular outcomes. As the team continues to monitor the patient's response to these interventions, they remain vigilant for any emerging signs of unstable angina or other complications that may necessitate further diagnostic evaluation or therapeutic adjustment.

Section 3

Two weeks after the adjustments in his beta-blocker dosage and the initiation of dietary interventions, the patient returns to the clinic for a follow-up visit. He reports a reduction in dizziness and fatigue, though he still experiences occasional episodes when he misses meals or stands up too quickly. A focused cardiovascular assessment reveals a blood pressure of 102/64 mmHg and a heart rate of 62 bpm, indicating improved hemodynamic stability compared to the previous visit. The patient has been attending the cardiac rehabilitation program regularly, which he describes as beneficial for both his physical activity levels and his understanding of heart-healthy living.

However, the patient now presents with new complaints of mild, intermittent shortness of breath and a sensation of palpitations, particularly during exertion or emotional stress. These symptoms prompt the healthcare team to consider the possibility of evolving cardiac complications. An ECG is performed in the clinic, revealing occasional premature ventricular contractions (PVCs), which could reflect increased cardiac irritability or electrolyte imbalances necessitating further investigation.

To address these new symptoms, the team orders laboratory tests, including serum electrolytes, thyroid function tests, and a repeat HbA1c. The results show a slightly elevated potassium level at 5.3 mmol/L, possibly influenced by dietary changes or medication effects. The patient's HbA1c has decreased modestly to 7.6%, demonstrating some progress in diabetes management, though further improvement is needed. The team discusses the potential need for an adjustment in his medication regimen and emphasizes the importance of adherence to dietary recommendations to prevent further complications. They schedule a follow-up appointment to re-evaluate his response to these interventions and to assess the need for further cardiac evaluation or treatment adjustments.

Section 4

Two weeks later, the patient returns for his scheduled follow-up appointment. During the initial assessment, he reports that his shortness of breath and palpitations have become more frequent, now occurring even with minimal exertion such as climbing a flight of stairs. He describes the palpitations as a fluttering sensation, lasting for a few seconds before subsiding. Despite these symptoms, he denies any chest pain or syncope. On examination, his vital signs reveal a blood pressure of 98/60 mmHg, a heart rate of 68 bpm, and a respiratory rate of 20 breaths per minute. Auscultation of the lungs reveals clear breath sounds, while cardiac auscultation detects occasional irregular beats consistent with PVCs noted previously.

The healthcare team decides to repeat the ECG, which now shows increased frequency of PVCs and occasional runs of ventricular tachycardia during exertion. Given these findings, the potential for electrolyte imbalances is revisited, and the team orders additional laboratory tests, including a repeat serum electrolytes evaluation. The results indicate that the potassium level remains elevated at 5.4 mmol/L, raising concerns about the risk of further cardiac arrhythmias. The patient's thyroid function tests are within normal limits, ruling out hyperthyroidism as a contributing factor. The clinical team considers whether the current medications, specifically the beta-blocker dose, might be contributing to the electrolyte disturbances and arrhythmias.

To address these complications, the team adjusts the patient's medication regimen by switching to a different beta-blocker with a more favorable side effect profile and advises on strict adherence to dietary modifications to manage potassium intake. Additionally, they recommend a more structured exercise program under supervision to monitor exertional symptoms closely. A referral is made to a cardiologist for further evaluation, including the potential need for a Holter monitor or stress test to assess the extent of arrhythmias and guide further treatment. The patient is educated on recognizing warning signs that would necessitate immediate medical attention, such as severe palpitations or chest pain. A follow-up appointment is scheduled to assess the effectiveness of these interventions and determine if further adjustments are necessary.

Section 5

Two weeks after the medication adjustment and dietary advice, the patient returns for a follow-up visit. He reports a slight improvement in his overall symptoms, noting that the palpitations have decreased in frequency, and he experiences shortness of breath only with more strenuous activities, such as brisk walking. However, he mentions a new symptom: mild dizziness when standing up quickly. He denies any instances of syncope or severe palpitations since the last visit. During the physical examination, his vital signs show a blood pressure of 92/58 mmHg, heart rate of 64 bpm, and a respiratory rate of 18 breaths per minute. Cardiac auscultation reveals fewer irregular beats compared to the previous visit, and lung sounds remain clear.

The healthcare team reviews the recent laboratory results, which indicate that while the patient's potassium level has decreased slightly to 5.2 mmol/L, it remains higher than desired. Other electrolytes, including sodium and magnesium, remain within normal ranges. Given the persistent low blood pressure and the new onset of orthostatic symptoms, the team considers the possibility that the current beta-blocker dose may still be affecting blood pressure regulation. As a result, they decide to adjust the beta-blocker dosage further while maintaining close monitoring of the patient's electrolyte levels and blood pressure.

To gain a more comprehensive understanding of the patient's cardiac rhythm and to assess the effectiveness of the current treatment plan, the team arranges for a Holter monitor to be worn for 48 hours. This will help in evaluating the frequency and severity of arrhythmias in the patient's day-to-day activities. Additionally, an exercise stress test is scheduled to determine the patient's cardiac response to physical exertion and to provide further insights into managing his stable angina and arrhythmias. The patient is advised to maintain his dietary restrictions and continue his supervised exercise regimen, with another follow-up appointment set to review the results of the Holter monitor and stress test.